==== Front Ann Saudi MedAnn Saudi MedAnnals of Saudi Medicine0256-49470975-4466King Faisal Specialist Hospital and Research Centre 2339602910.5144/0256-4947.2012.637asm-6-637Systematic ReviewAn epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population Sadat-Ali Mir aAl-Habdan Ibrahim M. aAl-Turki Haifa A bAzam Mohammed Quamar a a Department of Orthopaedic Surgery, University of Dammam King Fahd Hospital of the University, Al-Khobar, Saudi Arabia b Department of Obstetrics and Gynecology College of Medicine, University of Dammam King Fahd Hospital of the University, Al-Khobar, Saudi ArabiaCorrespondence: Prof Mir Sadat-Ali, PO Box 40071 King Fahd University Hospital Al-Khobar 31952 Saudi Arabia, T: +966505848281, F: +96638820887, drsadat@hotmail.comNov-Dec 2012 32 6 637 641 Copyright © 2012, Annals of Saudi Medicine2012This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.BACKGROUND AND OBJECTIVES Osteoporosis is common in Saudi Arabia and the burden of management in an aging population will increase in coming decades. There is still no national policy nor consensus on screening for this silent disease. The objective of this analysis was to determine from the published data the prevalence of osteopenia and osteoporosis in Saudi Arabians, the prevalence of secondary osteoporosis, and the prevalence of osteoporosis-related fractures (ORF). We also sought to determine the best age to begin and best modality for screening. METHODS Data Sources were MEDLINE (1966 to May 2011), EMBASE (1991 to May 2011), the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (1952 to May 2011), and the Science Citation Index (1966 to May 2011), published data from the Saudi Medical Journal (1985–2011) and Annals of Saudi Medicine (1985–2011). We selected English-language articles with at least 100 Saudi individuals. Two authors independently reviewed articles and abstracted data. RESULTS The authors identified 36 potentially relevant articles, of which 24 met the inclusion criteria. Of 5160 healthy women 50 to 79 years of age (mean, SD: 56.8 [2.7]), 36.6% (6.6%) were osteopenic and 34.0% (8.5%) were osteoporotic. In three studies on males (n=822), the prevalence of osteopenia was 46.3% and osteoporosis 30.7%. Males had a significantly higher frequency of osteopenia in comparison to females (P=<.001 95% CI<−0.0333), The mean age of the patients with secondary osteoporosis was 37.4 (13.5, 18–57) years, with the osteoporosis in 46.4% and osteopenia in 34.1%. In 5 studies of ORF, the incidence of vertebral fractures was between 20%–24%. CONCLUSION The currently available literature on Saudi Arabian population suggests that the ideal age for screening for low bone mass among the Saudi population should be earlier (55 years) than the ≥65 years in Western countries. Both quatitative ultrasound and dual-energy x-ray absorptiometry could be used for screening. The relatively small number of studies on Saudi Arabians and the different machines used for diagnosis limited the authors ability make conclusions with surety. ==== Body Osteoporosis and its related complications are one of the major healthcare problems around the globe. It is estimated that osteoporosis affects about 200 million women worldwide and is a substantial cause of morbidity and mortality. Fifty-four percent of postmenopausal white women are osteopenic and 30% are osteoporotic, and by the age of 80, 27% of women are osteopenic and 70% are osteoporotic.1 It is reported that about 40% of US white women and 13% of US white men aged 50 years will experience at least one fragility fracture in their lifetime.2 In 1990s it was realized that the problem of osteoporosis in Saudi Arabia was more severe than in the rest of the world with a reported prevalence between 30% to 48% in this country.3–9 Even though safe therapies are freely available for the treatment of osteoporosis and to reduce the risk of fractures,10–15 most affected individuals are asymptomatic, undiagnosed, and untreated.16–18 Moreover, the majority of patients at high risk who have already had at least one osteoporotic fracture, are neither identified nor treated adequately.19 Several organizations, including the US Preventive Services Task Force20 and International Osteoporosis Foundation21 recommend screening so as to make an early diagnosis of low bone mass, but in Saudi Arabia still there is no consensus on whom to screen, what age to screen and which modality to use. To be able to make any recommendations, we performed a systematic review to find answers to four questions, which we thought could help in formulating a future plan for Saudi Arabian patients with osteoporosis. First, what is the prevalence of postmenopausal osteoporosis, and male osteoporosis; secondly, how common is secondary osteoporosis; thirdly, what is the incidence of osteoporosis-related fractures (ORF); and lastly, at what age should screening be instituted and which modality used. METHODS We searched MEDLINE (1966 to May 2011), EMBASE (1991 to May 2011), the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (1952 to May 2011), and the Science Citation Index (1966 to May 2011), published data from the Saudi Medical Journal (1985–2011) and the Annals of Saudi Medicine (1985–2011). We supplemented our searches by manually reviewing bibliographies of eligible studies and relevant review articles. The key words selected were Saudi Arabia, osteopenia, osteoporosis and bone mineral density. The inclusion criteria were clinical studies involving at least 100 Saudi Arabian patients or healthy individuals. We included English language studies that diagnosed osteoporosis by radiographs, single photon absorptiometry (SPA), dual photon absorptiometry (DPA), dual-energy x-ray absorptiometry (DEXA) and calcaneal quantitative ultrasound (QUS). RESULTS The authors identified 36 potentially relevant articles, of which 24 met the inclusion criteria. Of 5160 healthy women 50 to 79 years of age (mean, SD: 56.8 [2.7]), 36.6% (6.6%) were osteopenic and 34.0% (8.5%) were osteoporotic (Table 1). In three studies on males (n=822), the prevalence of osteopenia was 46.3% and osteoporosis 30.7% (Table 2). The mean age of the patients with secondary osteoporosis was 37.4 (13.5, 18–57) years, with the osteoporosis in 46.4% and osteopenia in 34.1% (Table 3). Males had significantly higher osteopenic in comparison to females (P=<.001 95% CI <−0.0333) Osteopenia in women was 30.7% compared to 44.1% in men. The statistical comparison of osteopenia in women and men was that in 5160 women, osteopenia was reported in 1586, while in men out of 822 the osteopenia reported was in 365. Five studies which reported ORF data showed that the prevalence of femoral fractures in 1991 in men was 71/100 000 and 100/100 000 in women, while in 2007 it was 599/100 000 (men and women). The incidence of vertebral fractures was between 20% to 24% (Table 4). DISCUSSION Our systematic review of the published data indicate that the prevalence of low bone mass (osteoporosis and osteopenia) in Saudi Arabia is 70.5% in men and women with an average age of 56 years. This suggests that women in Saudi Arabia become osteoporotic earlier than the western women; hence it is recommended that if screening is to be mandated it should be around 55 years of age. The recent census of the Saudi population showed that the number of women aged ≥50 years is 906 526, which suggests that 326 349 (36%) are osteopenic and 308 612 (33%) are osteoporotic. The total population at risk of sustaining an ORF is 634 961. The World Health Organization estimated the prevalence of osteoporosis in Western women (adjusted to 1990 US white women) at any site as 14.8% in women aged 50–59, 21.6% for ages 60–69.39 Comparing the figures prevalence of osteoporosis in Saudi women is twice that of US white women and their suggestion is to screen women at ≥65 years for osteoporosis is not tenable; hence we believe that the screening for low bone mass in Saudi women should be at least a decade earlier. The analysis of studies published on male osteoporosis showed that the prevalence is similar to the postmenopausal group. Osteopenia in males is reported to be 46.3% while osteoporosis at 30.7%. The average at which the males suffer is at a much younger average age (57.4 [6.3]) years than in western countries. The prevalence of male osteoporosis is 7% in white men, 5% in black men, and about 3% in Hispanic-American men,40 while osteopenia in US men is reported to be 33% to 47%, which is similar to the 44.1% in the Saudi male population.41 Even in the male Saudi population we tend to believe that screening should be instituted earlier than recommended by the Western criteria. Secondary osteoporosis, which is caused by various disorders, metabolic derangements, drug administration and can be chemotherapy induced due to malignancies, still remains underdiagnosed and undertreated. Romagnoli et al42 reported the prevalence of primary osteoporosis to be significantly higher than secondary osteoporosis in both men and women. In our patients, secondary osteoporosis occurred in a young age group (mean age and SD, 37.4 [13.5] years) and higher than primary osteoporosis in men and women (46.4 [16.1] to 31.9 [1.6], P<.001, 95% CI<−13.4486). This comparison suggests that patients with known diseases and on medications which cause osteoporosis should be screened earlier, to institute early therapy and prevent complications of ORFs. Five studies on ORF reported 582 fractures in 2 071 400, making an incidence of 280 fractures per 100 000 population. A recently published study by Brauer and colleagues43 concluded that in the US the annual mean number of hip fractures was 957.3 per 100 000 for women and 414.4 per 100 000 for men. Our analysis shows that the annual prevalence of all ORF was 277.4/100 000. The prevalence reported in 1995 for femoral fractures was 50.7/100 000 and by 2007 the population of ≥50 years men and women was 164 128 and the number of femoral fractures was 984, giving a yearly prevalence of 599/100 000. Such an increase was observed in other countries as well due to aging of the population. Figures from United Kingdom showed the age-standardised incidence rates of fracture femurs increased by 32% in women and 38% in men,44 while Koh et al45 reported that hip fracture rates from 1991 to 1998 were 152/100 000 in men and 402/100 000 in women, and this was 1.5 and 5 times higher than corresponding rates in the 1960s. With the aging of the Saudi Arabian population, the number of fractures is expected to rise unless appropriate screening measures and adequate treatment is given. Various methodolgies have been used for screening for osteoporosis in different parts of the world. Currently, DEXA is the method of choice for measuring bone mass in the axial skeleton and is used for making a diagnosis of osteoporosis. DEXA allows accurate diagnosis of osteoporosis, estimation of fracture risk and monitoring of patients undergoing treatment. Additional features of DEXA include measurement of bone mineral density at multiple skeletal sites, safety of performance, short investigation time and ease of use.46–48 The use of QUS of the calcaneum came into vogue, to predict fracture risk due to low bone mass on the basis of calculation of the stiffness index, broadband ultrasound attenuation, speed of sound velocity, and T-score. The QUS is an inexpensive, radiation free, portable, and may provide information on bone quality and bone structure. Recently a new reference value for the diagnosis of low bone mass for the Saudi population has been assessed and reported.49 The reported sensitivity and specificity of the QUS in detecting low bone mass is around 90%.50,51 Studies also supported its routine use to predict fracture risk due to low bone mass.52,53 At present in Saudi Arabia, approximately 30% of women aged ≥56 years, 30.7% of men aged ≥60 years are expected to have osteoporosis and 25 percent of these women will develop a vertebral deformity due to fractures of the spine, and half of them will end up having a hip fracture. The authors thus conclude that screening for postmenopausal woman in the Saudi Arabian population should start at the age of 50 years and for male osteoporosis at 55 years so that early preventive measures may be instituted. An awareness program is needed to stress the need for early diagnosis of secondary osteoporosis. We further believe that screening either by ultrasound or DEXA could be used (though DEXA is more accurate and precise). Table 1 Studies with data on postmenopausal Saudi women. Studies No. of patients Age (y) Methodology Osteopenia n (%) Osteoporosis n (%) Al-Habdan et al (2009)5 3311 55.6 Ultrasonography 948 (30.3) 720 (23) Ardawi et al (2005)7 220 50–79a DEXA 95 (43.4) 62 (28.2) Sadat-Ali et al (2004)9 256 57.6 DEXA 79 (31) 107 (42) El Desouki (2003)6 830 59 DEXA 254 (30.6) (328) 39.5 El Desouki (1999)22 283 52–62a SPA (96) 34 68 (24) Sadat-Ali et al (1996)4 150 54.1 SPA 68 (45) 60 (40) Sadat-Ali et al(1993)3 110 58 Radiographs 46 (42) 45 (41) DEXA: dual-energy x-ray absorptiometry, SPA: single photon absorptiometry. Age data are mean and standard deviation. a mean age and SD not available in the publication Table 2 Studies with data on male osteoporosis. Studies No. of patients Age (y) Methodology Osteopenia n (%) Osteoporosis n (%) El-Desouki and Sulaimani (2007)23 429 53 (12.6) DEXA 158 (36.9) 101(23.5) Sadat-Ali and Al-Elq (2006)24 115 61.8 (1.8) DEXA 55 (47.9) 35(30.8) Ardawi et al (2005)7 278 50–79a DEXA 150 (54.1) 105(37.8) DEXA: dual-energy x-ray absorptiometry. Age data are mean and standard deviation. a mean age and SD not available in the publication Table 3 Reports on secondary osteoporosis. Studies Age (y) No. of patients Primary disease Methodology Osteopenia n (%) Osteoporosis n (%) Sadat-Ali et al (2011)25 28.4 186 Sickle cell disease DEXA 30 (16) 135 (72.5) Al-Turki H (2009)26 27.5 35 Sickle cell disease and pregnancy DEXA 14 (39.8) 21 (65) Al-Amri and Sadat-Ali (2009)27 49 71 Postchemotherapy DEXA 24 (33.9) 19 (26.8) Sadat-Ali et al (2008)28 30 87 Sickle cell disease DEXA 22 (25) 27 (31) Sadat-Ali et al (2009)29 38.3 165 Steroid use DEXA 81 (49.1) 48.3 Sadat-Ali et al (2008)30 18 32 Scoliosis DEXA 9 (28.1) 20 (62.5) Sadat-Ali and Al-Elq (2007)31 33 36 Sickle cell disease DEXA 7 (19.5) 14 (38.9) Al-Elq and Sadat-Ali (2006)32 57.5 154 Diabetes mellitus DEXA 80 (52) 40 (26) Al-Maatouq et al (2004)33 55 101 Diabetes mellitus DEXA 44 (43.6) 47 (46.8) DEXA: dual-energy x-ray absorptiometry. Age data are mean and standard deviation (when available). Table 4 Data related to osteoporosis-related fractures. Studies No. of patients Sex Methodology Site of Fractures n (%) Sadat-Ali et al (2011)34 980 Male Retrospective Vertebral 157 (13.1) Al-Osail, Sadat-Ali et al (2010)35 165 Male and female Retrospective All 25 (15.2) Sadat-Ali et al (2009)36 785 Female Retrospective Vertebral 159 (20.3) Bubshait and Sadat-Ali (2007)37 4910 Male and female Retrospective Proximal Femur 138 (2.8) Al-Nuaim et al (1995)38 203 000 Male and female Retrospective Proximal Femur 103 (0.05) ==== Refs REFERENCES 1 Melton LJ 3rd How many women have osteoporosis now? J Bone Miner Res 1995 10 175 7754796 2 Lindsay R Osteoporosis: a guide to diagnosis, prevention, and treatment New York Raven Press 1992 3 Sadat-Ali M El-Hassan AY Ezzeldin IM Postmenopausal osteoporosis in Saudi Women : A pilot screening Annals of Saudi Med 1993 13 272 74 4 Sadat-Al M Al-Habdan I Marwah S Bone Mineral Density measurements of distal radius in Saudi Arabian females Annals of Saudi Med 1996 16 4 414 16 5 Al-Habdan IM Sadat-Ali M Al-Muhanna FA Al-Elq AH Al-Mulhim AA Bone mass measurement using quantitative ultrasound in healthy Saudi women. A cross-sectional screening Saudi Med J 2009 11 30 11 1426 31 19882055 6 El-Desouki MI Osteoporosis in postmenopausal Saudi women using dual x-ray bone densitometry Saudi Med J 2003 9 24 9 953 56 12973476 7 Ardawi MS Maimany AA Bahksh TM Nasrat HA Milaat WA Al-Raddadi RM Bone mineral density of the spine and femur in healthy Saudis Osteoporos Int 2005 1 16 1 43 55 15167986 8 Sadat-Ali M Al-Habdan I Al-Mulhim AA Yousef A Effect of parity on Bone mineral density in Postmenopausal Saudi women Saudi Med J 2005 26 10 1588 90 16228061 9 Sadat-Ali Sadat-Ali M Al-Habdan I Al-Mulhim Fatma Yousef A Bone Mineral density among postmenopausal Saudi Arabian women Saudi Med J 2004 25 11 1623 25 15573189 10 Harris ST Watts NB Genant HK McKeever CD Hangartner T Keller M Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group JAMA 1999 282 1344 52 10527181 11 Black DM Cummings SR Karpf DB Cauley JA Thompson DE Nevitt MC Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 1996 348 1535 41 8950879 12 McClung MR Geusens P Miller PD Zippel H Bensen WG Roux C Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group N Engl J Med 2001 344 333 40 11172164 13 Ettinger B Black DM Mitlak BH Knickerbocker RK Nickelsen T Genant HK Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 1999 282 637 45 10517716 14 Delmas PD Ensrud KE Adachi JD Harper KD Sarkar S Gennari C Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial J Clin Endocrinol Metab 2002 87 3609 17 12161484 15 Neer RM Arnaud CD Zanchetta JR Prince R Gaich GA Reginster JY Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 2001 344 1434 41 11346808 16 Stafford RS Drieling RL Hersh AL National trends in osteoporosis visits and osteoporosis treatment, 1988–2003 Arch Intern Med 2004 164 1525 30 15277283 17 Freedman KB Kaplan FS Bilker WB 2000 Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am 82-A 1063 10954094 18 Siris ES Miller PD Barrett-Connor E Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment JAMA 2001 286 2815 11735756 19 Nguyen TV Center JR Eisman JA Osteoporosis: underrated, underdiagnosed and undertreated Med J Aust 2004 180 S18 14984358 20 U.S. Preventive Services Task Force Screening for osteoporosis in post-menopausal women: recommendations and rationale Ann Intern Med 2002 137 526 8 12230355 21 Kanis JA Burlet N Cooper C Delmas PD Reginster JY Borgstrom F European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 2008 10.1007/s00198-008-0560-z 22 El-Desouki M Osteoporosis In Postmenopausal Saudi Women Using Dual X-Ray Bone Densitometry Saudi Medical Journal 1999 20 4 283 286 27614484 23 El-Desouki MI Sulimani RA High prevalence of osteoporosis in Saudi men Saudi Med J 2007 5 28 5 774 7 17457450 24 Sadat-Ali M AlElq A Osteoporosis among male Saudi Arabs: a pilot study Ann Saudi Med 2006 Nov-Dec 26 6 450 4 17143021 25 Sadat-Ali M Al-Elq A Al-Turki H Sultan O Al- Ali A AlMulhim F Vitamin D level among patients with sickle cell anemia and its influence on bone mass Am J Hematol 2011 6 86 6 506 7 10.1002/ajh.22010 Epub 2011 Apr 20 21509795 26 Al-Turki H Influence of pregnancy on bone mass in sickle cell anemia West Afr J Med 2009 5 28 3 169 72 20306733 27 Al Amri A Sadat-Ali M Cancer chemotherapy-induced osteoporosis: How common is it among Saudi Arabian cancer survivors Indian J Cancer 2009 Oct-Dec 46 4 331 4 19749464 28 Sadat-Ali M Al-Elq AH Sultan O Al-Turki H Bukhari R Al-Mulhim E Low bone mass due to sickle cell anemia: is it becoming a real issue? West Afr J Med 2008 10 27 4 218 23 19469399 29 Sadat-Ali M Alelq AH Alshafei BA Al-Turki HA Abujubara MA Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy Ann Saudi Med 2009 May-Jun 29 3 215 8 19448373 30 Sadat-Ali M Al-Othman A Bubshait D Al-Dakheel D Does scoliosis causes low bone mass? A comparative study between siblings Eur Spine J 2008 7 17 7 944 7 Epub 2008 Apr 2 18427842 31 Sadat-Ali M Al Elq AH Sickle cell anaemia: is it a cause for secondary osteoporosis? West Afr J Med 2007 Apr-Jun 26 2 134 7 17939316 32 Al-Elq AH Sadat-Ali M Diabetes mellitus and male osteoporosis. Is there a relationship? Saudi Med J 2006 11 27 11 1729 33 17106551 33 Al-Maatouq MA El-Desouki MI Othman SA Mattar EH Babay ZA Addar M Prevalence of osteoporosis among postmenopausal females with diabetes mellitus Saudi Med J 2004 10 25 10 1423 7 15494815 34 Sadat-Ali M Gullenpet AH Al-Turki HA Abdulrahman TW Al-Elq AH Azzam MQ Are we missing osteoporosis-related vertebral fractures in men? Asian Spine J 2011 6 5 2 107 10 21629485 35 Al-Osail AM Sadat-Ali M Al-Elq AH Al-Omran AS Azzam Q Glucocorticoid-related osteoporotic fractures Singapore Med J 2010 12 51 12 948 5 21221500 36 Sadat-Ali M Gullenpet AH Al-Mulhim F Al Turki H Al-Shammary H Al-Elq A Osteoporosis-related vertebral fractures in postmenopausal women: prevalence in a Saudi Arabian sample East Mediterr Health J 2009 Nov-Dec 15 6 1420 5 20218133 37 Bubshait D Sadat-Ali M Economic implications of osteoporosis-related femoral fractures in Saudi Arabian society Calcif Tissue Int 2007 12 81 6 455 8 Epub 2007 Dec 4 18066484 38 al-Nuaim AR Kremli M al-Nuaim M Sandkgi S Incidence of proximal femur fracture in an urbanized community in Saudi Arabia Calcif Tissue Int 1995 6 56 6 536 8 7648482 39 World Health Organisation Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis WHO Technical report Series 843 Geneva WHO 1994 40 Looker AC Orwoll ES Johnston CC Jr Lindsay RL Wahner HW Dunn WL Prevalence of low femoral bone density in older U.S. adults from NHANES III J Bone Miner Res 1997 12 1761 8 9383679 41 Bilezikian JP Osteoporosis in men J Clin Endocrinol Metab 1999 84 3431 4 10522975 42 Romagnoli E Del Fiacco R Russo S Piemonte S Fidanza F Colapietro F Secondary Osteoporosis in Men and Women: Clinical Challenge of an Unresolved Issue Rheumatol 2011 6 1 Epub ahead of print 43 Brauer CA Perraillon MC Cutler DM Rosen AB Incidence and mortality of hip fractures in the United States Journal of the American Medical Association 2009 302 14 1573 79 19826027 44 Balasegaram S Majeed A Fitz-Clarence H Trends in hospital admissions for fractures of the hip and femur in England, 1989–1990 to 1997–1998 Journal of Public Health Medicine 2001 23 1 11 17 11315687 45 Koh LKH Saw SM Lee JJM Leong KH Lee J National Working Committee on Osteoporosis Hip fracture incidence rates in Singapore 1991–1998 Osteoporosis International 2001 12 4 311 18 11420781 46 Blake GM Fogelman I The role of DXA bone density scans in the diagnosis and treatment of osteoporosis Postgrad Med J 2007 83 509 17 17675543 47 Writing Group for the ISCD Position Development Conference Indications and reporting for dual-energy x-ray absorptiometry J Clin Densitom 2004 7 37 44 14742886 48 Lewiecki EM Binkley N Petak SM DXA quality matters J Clin Densitom 2006 9 388 92 17097522 49 Sadat-Ali M Al-Elq A Al-Habdan IM Al-Mohanna FA Al-Mulhim AA Quantitative ultrasound (QUS) of the os calcis in Saudi women: defining Saudi reference value for the diagnosis of low bone mass Arch Osteoporos 2010 5 139 144 10.1007/s11657-010-0047-3 50 Hans D Downs RW Jr Duboeuf F Greenspan S Jankowski LG Kiebzak GM Skeletal sites for osteoporosis diagnosis: the 2005 ISCD official positions J Clin Densitom 2006 9 15 21 16731427 51 Hans D Hartl F Krieg MA Device-specific weighted T-score for two quantitative ultrasounds: operational propositions for the management of osteoporosis for 65 years and older women in Switzerland Osteoporos Int 2003 14 3 251 258 12730788 52 Clowes JA Peel NF Eastell R Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice Osteoporos Int 2006 17 9 1293 1302 16810454 53 Schott AM Kassaï Koupaï B Hans D Dargent-Molina P Ecochard R Bauer DC Should age influence the choice of quantitative bone assessment technique in elderly women? The EPIDOS study Osteoporos Int 2004 15 3 196 203 14735300